Financials

  • Market Capitalization 768.44 M
  • Employee 29
  • Founded 2018
  • CEO N/A
  • Website www.climbbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00ZNKL0K6
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.55
Rapporto prezzo/fatturato
-932.13

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2631
ZVRA
Zevra Therapeutics, Inc. - Common Stock
13.18 USD0.00%-8.85%+2.89%+23.87%779.14 M USD
2635
OMER
Omeros Corporation - Common Stock
10.62 USD+6.09%+3.91%+20.41%+168.18%768.63 M USD
2637
RIGL
Rigel Pharmaceuticals, Inc. - Common Stock
41.50 USD+0.48%-0.12%+24.85%+37.74%767.84 M USD
2649
SPRY
ARS Pharmaceuticals, Inc. - Common Stock
7.58 USD-2.07%-9.87%-23.05%-17.70%752.72 M USD